MedPath

terine Fibroids-Effect of Ayurvedic regime

Phase 2
Conditions
Health Condition 1: null- Uterine Fibroids
Registration Number
CTRI/2014/09/005018
Lead Sponsor
Central Council for Research in Ayurvedic Sciences CCRAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Symptomatic Females, 25-50 yrs

Uterine fibroids, uterine size < 12 weeks, and at least one fibroid >2 cm but none >5 cm on U/S

Pre menopausal ladies with Uterine Fibroids getting at least 1 menstrual period in last three months.

Normal PAP smear.

Exclusion Criteria

Pregnancy, Lactation.

Unexplained vaginal bleeding, cervical dysplasia, abnormal ovarian or adnexal mass.

History of malignancy within the past 5 years.

Use of estrogen or progesterone-containing compounds, such as oral contraceptives and hormone replacement therapy, within 8 weeks of study entry, including transdermal, injectable, vaginal and oral preparations.

Use of herbal medication having estrogenic or antiestrogenic effect within the past 3 months.

Known recent rapid growth of fibroids, defined as a doubling in size in six months.

Haemoglobin level below 8gm%

Patients suffering from any other major systemic illness necessitating long term drug Therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the clinical symptomsTimepoint: At base line 30th day, 60th day, 90th day, 120th day, 150th day and 180th day i.e at the time of trial completion
Secondary Outcome Measures
NameTimeMethod
Changes in the size of fibroidsTimepoint: At the screening day, 90th day and end of the study (180th day)
© Copyright 2025. All Rights Reserved by MedPath